- Home
- CRVO vs QUCY Comparison
CRVO vs QUCY Comparison
Compare CRVO & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.13
Company Overview
Basic Information| Metric | CRVO | QUCY |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | Germany |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3M | 33.5M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRVO | QUCY |
|---|---|---|
| Price | $3.13 | $1.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 15.7M | 2.7M |
| Earning Date | 05-12-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | $74.34 |
| Revenue Next Year | N/A | $171.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.13 | $0.30 |
| 52 Week High | $13.13 | $4.93 |
Technical Indicators
Market Signals| Indicator | CRVO | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 37.90 |
| Support Level | $2.82 | $0.38 |
| Resistance Level | $4.03 | $2.36 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 20.96 | 21.76 |
Price Performance
Historical Comparison CRVO
QUCY
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About QUCY Mainz Biomed N.V. Ordinary Shares
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.